Hematologic Malignancies
News
Giving Dexamethasone a New Lease on Life
New findings support the idea of changing treatment for adverse effects of chemotherapy to a treatment for fighting the cancer.
News
FDA places partial hold on trials after secondary lymphoma
A pediatric patient developed a secondary T-cell lymphoma during a phase 1 trial of tazemetostat.
News
PDPK1 could be novel target in MCL
The poor prognosis of mantle cell lymphoma despite advances in immunochemotherapy means that new therapeutic targets are needed.
News
Updated CLL guidelines incorporate a decade of advances
Advances in genomics, diagnostics and therapies since 2008 are reflected in the guidelines.
Article
Clinical Puzzle: Lung Cancer or Hodgkin Lymphoma?
Making the right diagnosis when radiologic evidence is misleading.
News
FDA approves new option in Hodgkin lymphoma treatment
The approval is based on results from the ECHELON-1 trial in previously untreated patients with stage III or IV classical Hodgkin lymphoma.
News
More evidence links increased BMI to higher multiple myeloma risk
MM risk rose almost 30% for every 5 kg/m2 increase in young adult BMI.
News
In myeloma, third ASCT is a viable option
The analysis identifies relapse-free interval as a prognostic factor.
News
A global snapshot of leukemia incidence
United States is on the high side for all four subtypes of the disease.
News
Acalabrutinib shows less off-target activity in mantle cell lymphoma
The findings add to a growing body of evidence showing that BTK inhibition disrupts the tumor microenvironment.